CD274 and cancer: The resulting nanoparticles can escape from the early endosome and accumulate in the lysosomes of HeLa cells (up to 12 h and 32%).439 Xu and colleagues identified a novel LSP that can target the delivery of PD-L1 on the surface of cancer cells to the lysosome by conjugating with a PD-L1 binding signal.